Joanne Verheij

ORCID: 0000-0003-1283-630X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Gallbladder and Bile Duct Disorders
  • Immunotherapy and Immune Responses
  • Pancreatitis Pathology and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • Neuroendocrine Tumor Research Advances
  • Cancer Genomics and Diagnostics
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Pediatric Hepatobiliary Diseases and Treatments
  • Eosinophilic Esophagitis
  • Congenital gastrointestinal and neural anomalies
  • IgG4-Related and Inflammatory Diseases
  • Drug Transport and Resistance Mechanisms
  • Renal cell carcinoma treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Organ Transplantation Techniques and Outcomes
  • Hepatitis B Virus Studies
  • Genetic and Kidney Cyst Diseases
  • Eosinophilic Disorders and Syndromes
  • Diet, Metabolism, and Disease

University of Amsterdam
2016-2025

Amsterdam University Medical Centers
2016-2025

Cancer Center Amsterdam
2018-2025

Dutch Cancer Society
2025

University Medical Center Groningen
2015-2024

University of Groningen
2015-2024

Amsterdam UMC Location University of Amsterdam
2012-2022

Emma Kinderziekenhuis
2021

Metropolitan University
2016-2021

John Wiley & Sons (United Kingdom)
2020

Jony van Hilst Thijs de Rooij K. Bosscha David J. Brinkman Susan van Dieren and 95 more Marcel G. W. Dijkgraaf Michael F. Gerhards Ignace H. J. T. de Hingh Tom M. Karsten Daniel J. Lips Misha Luyer Olivier R. Busch Sebastiaan Festen Marc G. Besselink Jony van Hilst Thijs de Rooij K. Bosscha David J. Brinkman Susan van Dieren Marcel G. W. Dijkgraaf Michael F. Gerhards Ignace H. J. T. de Hingh Tom M. Karsten Daniel J. Lips Misha Luyer Olivier R. Busch Sebastiaan Festen Marc G. Besselink Hendrik A. Marsman Thomas M. van Gulik Dennis A. Wicherts Wietse J. Eshuis Luna A. Stibbe Els J. Nieveen van Dijkum Janine E Van Hooft Paul Fockens Hanneke W.M. van Laarhoven Johanna W. Wilmink Marcel J Van de Vijver Maarten F. Bijlsma Joanne Verheij C. Yung Nio Krijn P. van Lienden Geertjan van Tienhoven Annuska Schoorlemmer Geert-Jan Creemers Casper HJ van Eijck Bas Groot Koerkamp Marco J. Bruno Ferry A.L.M. Eskens Joost J. Nuyttens Chulja J. Pek George P. van der Schelling Tom Seerden Gijs A. Patijn Vincent B. Nieuwenhuijs Jan Willem de Groot Bert A. Bonsing Alexander L. Vahrmeijer Rutger‐Jan Swijnenburg J. Sven D. Mieog Erwin van der Harst Marcel den Dulk Steven W.M. Olde Damink C. Dejong Ronald M. van Dam Judith MPGM De Vos Mike S.L. Liem Cees J. van Laarhoven Harry van Goor Peter B. van den Boezem B M van der Kolk Martijn W.J. Stommel John J. Hermans Erwin JM van Geenen Sandra A. Radema Lodewijk A.A. Brosens Joris J. Scheepers Daphne Roos Djamilla Boerma Wouter te Riele Hjalmar C. van Santvoort Thomas L. Bollen Fanny Wit I. Quintus Molenaar Nadia Haj Mohammad Maarten S. van Leeuwen Annemarie Roele Kees P De Jong Vincent E. de Meijer Joost M. Klaase Geert Kazemier Babs M. Zonderhuis Freek Daams Martijn R. Meijerink Anouk E.J. Latenstein L. Bengt van Rijssen Carolijn L. Nota Emo van Halsema Eran van Veldhuisen

10.1016/s2468-1253(19)30004-4 article EN ˜The œLancet. Gastroenterology & hepatology 2019-01-27

<h3>Importance</h3> The recently released eighth edition of the American Joint Committee on Cancer TNM staging system for pancreatic cancer seeks to improve prognostic accuracy but lacks international validation. <h3>Objective</h3> To validate in an cohort patients with resected ductal adenocarcinoma. <h3>Design, Setting, and Participants</h3> This multicenter study took place 5 tertiary centers Europe United States from 2000 2015. Patients who underwent pancreatoduodenectomy nonmetastatic...

10.1001/jamasurg.2018.3617 article EN JAMA Surgery 2018-10-03

<h3>Objective</h3> The value of surveillance for patients with Barrett9s oesophagus (BO) is under discussion given the overall low incidence neoplastic progression and lack discriminative tests risk stratification. Histological diagnosis low-grade dysplasia (LGD) only accepted predictor to date, but has a predictive value. aim this study was therefore evaluate p53 immunohistochemistry predicting in BO. <h3>Design</h3> We conducted case–control within prospective cohort 720 Patients who...

10.1136/gutjnl-2012-303594 article EN Gut 2012-12-20

PurposeUsing exome sequencing, the underlying variants in many persons with autosomal recessive diseases remain undetected. We explored Stargardt disease (STGD1) as a model to identify missing heritability.MethodsSequencing of ABCA4 was performed 8 STGD1 cases one variant and p.Asn1868Ile trans, 25 variant, 3 no variant. The effect intronic analyzed using vitro splice assays HEK293T cells patient-derived fibroblasts. Antisense oligonucleotides were used correct defects.ResultsIn 24 probands...

10.1038/s41436-018-0414-9 article EN cc-by Genetics in Medicine 2019-01-14
Maarten Korrel L. Jones Jony van Hilst Gianpaolo Balzano Bergþór Björnsson and 88 more Ugo Boggi Svein Olav Bratlie Olivier R. Busch Giovanni Butturini Giovanni Capretti Riccardo Casadei Bjørn Edwin Anouk M.L.H. Emmen Alessandro Esposito Massimo Falconi Bas Groot Koerkamp Tobias Keck Ruben H.J. de Kleine Dyre Kleive Arto Kokkola Daan J. Lips Sanne Lof Misha Luyer Alberto Manzoni Ravi Marudanayagam Matteo De Pastena Nicolò Pecorelli John Primrose Claudio Ricci Roberto Salvia Per Sandström Frederique L. Vissers Ulrich F. Wellner Alessandro Zerbi Marcel G. W. Dijkgraaf Marc G. Besselink Mohammad Abu Hilal Adnan Alseidi Constanza Aquilano Johanna Arola Denise Bianchi Rachel M. Brown Daniela Campani Joanne Chin–Aleong Jérôme Cros Lyubomira Dimitrova Claudio Doglioni Safi Dokmak Russell Dorer Michael Doukas J Fabré Giovanni Ferrari В. Н. Гриневич Stefano Gobbo Thilo Hackert Marius van den Heuvel Clement Huijsentruijt Mar Iglesias Casper Jansen Igor Khatkov David A. Kooby Marco Schiavo Lena Claudio Luchini Krishna Menon Patrick Michenet Q. Molenaar Anna Nedkova Andrea Pietrabissa Mihaela Raicu Rushda Rajak Branislava Ranković Aniko Rendek Benjamin Rivière António Sá Cunha Olivier Saint Marc Patricia Sánchez‐Velázquez Donatella Santini Aldo Scarpa Mylène Sebagh Donald L. Sears Mihir M. Shah Zahir Soonawalla Paola Spaggiari Lars Tharun Tore Tholfsen Aleš Tomažič Alessandro Vanoli Caroline S. Verbeke Joanne Verheij Moritz von Winterfeld Roeland F. de Wilde Vincent Yip Yoh Zen

The oncological safety of minimally invasive surgery has been questioned for several abdominal cancers. Concerns also exist regarding the use distal pancreatectomy (MIDP) in patients with resectable pancreatic cancer as randomised trials are lacking.In this international non-inferiority trial, we recruited adults from 35 centres 12 countries. Patients were randomly assigned to either MIDP (laparoscopic or robotic) open (ODP). Both and pathologists blinded approach. Primary endpoint was...

10.1016/j.lanepe.2023.100673 article EN cc-by-nc-nd The Lancet Regional Health - Europe 2023-07-06
Michèle Vacca Ioannis Kamzolas Lea Mørch Harder Fiona Oakley Christian Trautwein and 95 more Maximilian Hatting Trenton T. Ross Barbara Bernardo Anouk Oldenburger Sara Toftegaard Hjuler Iwona Ksiazek Daniel Lindén Detlef Schuppan Sergio Rodríguez‐Cuenca Maria Manuela Tonini Tamara R. Castañeda Aimo Kannt Cecília M. P. Rodrigues Simon Cockell Olivier Govaere Ann K. Daly Michael Allison Kristian Honnens de Lichtenberg Yong Ook Kim Anna Lindblom Stephanie Oldham Anne‐Christine Andréasson Franklin Schlerman Jonathon Marioneaux Arun J. Sanyal Marta B. Afonso Ramy Younes Yuichiro Amano Scott L. Friedman Shuang Wang Dipankar Bhattacharya Eric J. Simon Valérie Paradis Alastair D. Burt Ioanna Maria Grypari Susan Davies Ann Driessen Hiroaki Yashiro Susanne Elisabeth Pors M Andersen Michael Feigh Carla Yunis Pierre Bédossa Michelle Stewart Heather Cater Sara Wells Jörn M. Schattenberg Quentin M. Anstee Quentin M. Anstee Ann K. Daly Simon Cockell Dina Tiniakos Pierre Bédossa Alastair D. Burt Fiona Oakley Heather J. Cordell Christopher P. Day Kristy Wonders Paolo Missier Matthew McTeer Luke Vale Yemi Oluboyede Matt Breckons Jo Boyle Patrick M. Bossuyt Hadi Zafarmand Yasaman Vali Jenny Lee Max Nieuwdorp Adriaan G. Holleboom Athanasios Angelakis Joanne Verheij Vlad Ratziu Karine Clément Rafael Patiño‐Navarrete Raluca Pais Valérie Paradis Detlef Schuppan Jörn M. Schattenberg Rambabu Surabattula Sudha Rani Myneni Yong Ook Kim Beate K. Straub António Vidal-Puig Michèle Vacca Sergio Rodrigues-Cuenca Mike Allison Ioannis Kamzolas Evangelia Petsalaki Mark Campbell Chris Lelliott Nathan Davies Matej Orešič Tuulia Hyötyläinen Aidan McGlinchey

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty disease, encompasses steatosis and metabolic steatohepatitis (MASH), leading to cirrhosis hepatocellular carcinoma. Preclinical MASLD research is mainly performed in rodents; however, the model that best recapitulates human yet be defined. We conducted a wide-ranging retrospective review (metabolic phenotype, histopathology, transcriptome benchmarked against humans) of murine...

10.1038/s42255-024-01043-6 article EN cc-by Nature Metabolism 2024-06-12

To investigate the correlation between magnetic resonance (MR) imaging findings and pathologic subtype classification of hepatocellular adenoma (HCA).This retrospective study was approved by institutional review board, requirement for informed consent waived. MR studies 61 lesions (48 patients; median age, 36 years) were available independently reviewed two radiologists. Consensus readings on all morphologic signal-intensity features obtained. Previously, these had been classified basis...

10.1148/radiol.11110023 article EN Radiology 2011-08-27

A randomized, double-blind, placebo-controlled study was conducted to investigate the safety and efficacy of mipomersen, an apolipoprotein B-100 (apoB) synthesis inhibitor, in patients who are statin intolerant at high risk for cardiovascular disease (CVD).Thirty-three subjects, not receiving therapy because intolerance, received a weekly subcutaneous dose 200 mg mipomersen or placebo (2:1 randomization) 26 weeks. The primary endpoint per cent change LDL cholesterol (LDL-c) from baseline...

10.1093/eurheartj/ehs023 article EN cc-by-nc European Heart Journal 2012-04-17

Abstract Background Recent literature has shown increasing incidence and prevalence rates of eosinophilic esophagitis (EoE). However, data are mainly based on small studies come from centers dedicated to EoE. Aim this study was estimate the EoE by using a large database. Methods We performed cross‐sectional pathology reports describing esophageal eosinophilia 1996 through 2010, nationwide network registry histo‐ cytopathology in The Netherlands (PALGA). All histopathology enter classified...

10.1111/nmo.12009 article EN Neurogastroenterology & Motility 2012-09-10

Abstract The mechanisms that enable liver cancer to escape elimination by the immune system remain unclear, but their elucidation may provide novel therapeutic interventions. We investigated influence of tumor-infiltrating regulatory T cells on tumor-specific cell responses in patients with cancer, using ex vivo isolated from individuals hepatocellular carcinoma (HCC) or metastases colorectal (LM-CRC). Here we report both HCC and LM-CRC, CD4+CD25+Foxp3+ (Tregs) accumulate tumor milieu are...

10.1002/hep.26013 article EN Hepatology 2012-08-22

Objective: To compare crystalloid and colloid fluids in their effect on pulmonary edema hypovolemic septic nonseptic patients with or at risk for acute lung injury/acute respiratory distress syndrome. We hypothesized that 1) loading results more formation than 2) the differences among types of fluid decreases high permeability. Design, Setting, Patients: Prospective randomized clinical trial 24 mechanically ventilated hypovolemia. Interventions: Patients were assigned to NaCl 0.9%, gelatin...

10.1097/ccm.0b013e31819cedfd article EN Critical Care Medicine 2009-04-01

Abstract Immunoglobulin G4 (IgG4)-associated cholangitis (IAC) is a manifestation of the recently discovered idiopathic IgG4-related disease. The majority patients have elevated serum IgG4 levels and/or IgG4-positive B-cell and plasma cell infiltrates in affected tissue. We hypothesized that clonally expanded, class-switched B cells could be causal to these poorly understood phenomena. In prospective cohort six consecutive IAC patients, healthy controls, disease we used novel next-generation...

10.1002/hep.26232 article EN Hepatology 2013-01-09

BackgroundIn recent years, new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC) including 5-fluorouracil, leucovorin, irinotecan and oxaliplatin. The impact hereof has not been assessed in nationwide cohort studies. This population-based study aimed to investigate trends incidence, survival of PDAC.Materials methodsPatients with PDAC (1997–2016) were included from the Netherlands Cancer Registry. Results categorised by period diagnosis (1997–2000,...

10.1016/j.ejca.2019.11.002 article EN cc-by-nc-nd European Journal of Cancer 2019-12-13

Inherited eye disorders have a large clinical and genetic heterogeneity, which makes diagnosis cumbersome. An exome-sequencing approach was developed in data analysis divided into two steps: the vision gene panel exome analysis. In analysis, variants genes known to cause inherited were assessed for pathogenicity. If no causative detected when patient consented, entire analyzed. A total of 266 Dutch patients with different types disorders, including retinal dystrophies, cataract,...

10.1038/ejhg.2017.9 article EN cc-by-nc-nd European Journal of Human Genetics 2017-02-22

Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of resistance by HCC crucial development suitable immunotherapeutics. We used immunohistochemistry on tissue-microarrays to examine co-expression inhibiting molecules PD-L1, Galectin-9, HVEM and IDO, as well tumor CD8+ lymphocyte infiltration in HCC, two independent cohorts patients. found at...

10.1080/2162402x.2016.1273309 article EN OncoImmunology 2017-01-03
Coming Soon ...